Global Hepatitis A Viruses Rapid Testing Market Growth 2025-2031

Publication ID:

LPI08257396

Publication Date:

August 11, 2025

Pages:

132

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Hepatitis A Viruses Rapid Testing market size is predicted to grow from US$ 1578 million in 2025 to US$ 2002 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Hepatitis A Virus (HAV) Rapid Test is a point-of-care in vitro diagnostic technique that detects hepatitis A virus antigens or antibodies in human samples (e.g., serum, plasma, whole blood, or stool) within a short time frame (typically 15-30 minutes) using immunological principles such as colloidal gold or lateral flow immunoassay. Its primary purpose is to rapidly screen for acute or past HAV infections. This test is characterized by its simplicity, instrument-free operation, and suitability for primary healthcare settings, emergency scenarios, or infectious disease control in resource-limited areas.
United States market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hepatitis A Viruses Rapid Testing players cover Roche Diagnostics, Abbott Rapid Diagnostics, GSK, Merck, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淗epatitis A Viruses Rapid Testing Industry Forecast鈥� looks at past sales and reviews total world Hepatitis A Viruses Rapid Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis A Viruses Rapid Testing sales for 2025 through 2031. With Hepatitis A Viruses Rapid Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis A Viruses Rapid Testing industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis A Viruses Rapid Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis A Viruses Rapid Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Hepatitis A Viruses Rapid Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis A Viruses Rapid Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis A Viruses Rapid Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Viruses Rapid Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood Tests
Non-Blood Tests
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott Rapid Diagnostics
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Bio-Rad Laboratories
Wondfo
Wantai Bio
Siemens Healthineers
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hepatitis A Viruses Rapid Testing market?
What factors are driving Hepatitis A Viruses Rapid Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis A Viruses Rapid Testing market opportunities vary by end market size?
How does Hepatitis A Viruses Rapid Testing break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis A Viruses Rapid Testing Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hepatitis A Viruses Rapid Testing by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hepatitis A Viruses Rapid Testing by Country/Region, 2020, 2024 & 2031
2.2 Hepatitis A Viruses Rapid Testing Segment by Type
2.2.1 Blood Tests
2.2.2 Non-Blood Tests
2.3 Hepatitis A Viruses Rapid Testing Sales by Type
2.3.1 Global Hepatitis A Viruses Rapid Testing Sales Market Share by Type (2020-2025)
2.3.2 Global Hepatitis A Viruses Rapid Testing Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hepatitis A Viruses Rapid Testing Sale Price by Type (2020-2025)
2.4 Hepatitis A Viruses Rapid Testing Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Hepatitis A Viruses Rapid Testing Sales by Application
2.5.1 Global Hepatitis A Viruses Rapid Testing Sale Market Share by Application (2020-2025)
2.5.2 Global Hepatitis A Viruses Rapid Testing Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hepatitis A Viruses Rapid Testing Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Hepatitis A Viruses Rapid Testing Breakdown Data by Company
3.1.1 Global Hepatitis A Viruses Rapid Testing Annual Sales by Company (2020-2025)
3.1.2 Global Hepatitis A Viruses Rapid Testing Sales Market Share by Company (2020-2025)
3.2 Global Hepatitis A Viruses Rapid Testing Annual Revenue by Company (2020-2025)
3.2.1 Global Hepatitis A Viruses Rapid Testing Revenue by Company (2020-2025)
3.2.2 Global Hepatitis A Viruses Rapid Testing Revenue Market Share by Company (2020-2025)
3.3 Global Hepatitis A Viruses Rapid Testing Sale Price by Company
3.4 Key Manufacturers Hepatitis A Viruses Rapid Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A Viruses Rapid Testing Product Location Distribution
3.4.2 Players Hepatitis A Viruses Rapid Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Hepatitis A Viruses Rapid Testing by Geographic Region
4.1 World Historic Hepatitis A Viruses Rapid Testing Market Size by Geographic Region (2020-2025)
4.1.1 Global Hepatitis A Viruses Rapid Testing Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hepatitis A Viruses Rapid Testing Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hepatitis A Viruses Rapid Testing Market Size by Country/Region (2020-2025)
4.2.1 Global Hepatitis A Viruses Rapid Testing Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hepatitis A Viruses Rapid Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hepatitis A Viruses Rapid Testing Sales Growth
4.4 APAC Hepatitis A Viruses Rapid Testing Sales Growth
4.5 Europe Hepatitis A Viruses Rapid Testing Sales Growth
4.6 Middle East & Africa Hepatitis A Viruses Rapid Testing Sales Growth
5 Americas
5.1 Americas Hepatitis A Viruses Rapid Testing Sales by Country
5.1.1 Americas Hepatitis A Viruses Rapid Testing Sales by Country (2020-2025)
5.1.2 Americas Hepatitis A Viruses Rapid Testing Revenue by Country (2020-2025)
5.2 Americas Hepatitis A Viruses Rapid Testing Sales by Type (2020-2025)
5.3 Americas Hepatitis A Viruses Rapid Testing Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A Viruses Rapid Testing Sales by Region
6.1.1 APAC Hepatitis A Viruses Rapid Testing Sales by Region (2020-2025)
6.1.2 APAC Hepatitis A Viruses Rapid Testing Revenue by Region (2020-2025)
6.2 APAC Hepatitis A Viruses Rapid Testing Sales by Type (2020-2025)
6.3 APAC Hepatitis A Viruses Rapid Testing Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis A Viruses Rapid Testing by Country
7.1.1 Europe Hepatitis A Viruses Rapid Testing Sales by Country (2020-2025)
7.1.2 Europe Hepatitis A Viruses Rapid Testing Revenue by Country (2020-2025)
7.2 Europe Hepatitis A Viruses Rapid Testing Sales by Type (2020-2025)
7.3 Europe Hepatitis A Viruses Rapid Testing Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis A Viruses Rapid Testing by Country
8.1.1 Middle East & Africa Hepatitis A Viruses Rapid Testing Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hepatitis A Viruses Rapid Testing Revenue by Country (2020-2025)
8.2 Middle East & Africa Hepatitis A Viruses Rapid Testing Sales by Type (2020-2025)
8.3 Middle East & Africa Hepatitis A Viruses Rapid Testing Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A Viruses Rapid Testing
10.3 Manufacturing Process Analysis of Hepatitis A Viruses Rapid Testing
10.4 Industry Chain Structure of Hepatitis A Viruses Rapid Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A Viruses Rapid Testing Distributors
11.3 Hepatitis A Viruses Rapid Testing Customer
12 World Forecast Review for Hepatitis A Viruses Rapid Testing by Geographic Region
12.1 Global Hepatitis A Viruses Rapid Testing Market Size Forecast by Region
12.1.1 Global Hepatitis A Viruses Rapid Testing Forecast by Region (2026-2031)
12.1.2 Global Hepatitis A Viruses Rapid Testing Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hepatitis A Viruses Rapid Testing Forecast by Type (2026-2031)
12.7 Global Hepatitis A Viruses Rapid Testing Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.1.3 Roche Diagnostics Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Abbott Rapid Diagnostics
13.2.1 Abbott Rapid Diagnostics Company Information
13.2.2 Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.2.3 Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abbott Rapid Diagnostics Main Business Overview
13.2.5 Abbott Rapid Diagnostics Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.3.3 GSK Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.4.3 Merck Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.5.3 Sanofi Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Sinovac
13.6.1 Sinovac Company Information
13.6.2 Sinovac Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.6.3 Sinovac Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sinovac Main Business Overview
13.6.5 Sinovac Latest Developments
13.7 Zhejiang Pukang
13.7.1 Zhejiang Pukang Company Information
13.7.2 Zhejiang Pukang Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.7.3 Zhejiang Pukang Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zhejiang Pukang Main Business Overview
13.7.5 Zhejiang Pukang Latest Developments
13.8 Changchun Institute of Biological
13.8.1 Changchun Institute of Biological Company Information
13.8.2 Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.8.3 Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changchun Institute of Biological Main Business Overview
13.8.5 Changchun Institute of Biological Latest Developments
13.9 KM Biologics
13.9.1 KM Biologics Company Information
13.9.2 KM Biologics Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.9.3 KM Biologics Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 KM Biologics Main Business Overview
13.9.5 KM Biologics Latest Developments
13.10 IMBCA
13.10.1 IMBCA Company Information
13.10.2 IMBCA Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.10.3 IMBCA Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 IMBCA Main Business Overview
13.10.5 IMBCA Latest Developments
13.11 ChangSheng
13.11.1 ChangSheng Company Information
13.11.2 ChangSheng Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.11.3 ChangSheng Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 ChangSheng Main Business Overview
13.11.5 ChangSheng Latest Developments
13.12 Convac
13.12.1 Convac Company Information
13.12.2 Convac Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.12.3 Convac Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Convac Main Business Overview
13.12.5 Convac Latest Developments
13.13 Bio-Rad Laboratories
13.13.1 Bio-Rad Laboratories Company Information
13.13.2 Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.13.3 Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Bio-Rad Laboratories Main Business Overview
13.13.5 Bio-Rad Laboratories Latest Developments
13.14 Wondfo
13.14.1 Wondfo Company Information
13.14.2 Wondfo Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.14.3 Wondfo Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Wondfo Main Business Overview
13.14.5 Wondfo Latest Developments
13.15 Wantai Bio
13.15.1 Wantai Bio Company Information
13.15.2 Wantai Bio Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.15.3 Wantai Bio Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Wantai Bio Main Business Overview
13.15.5 Wantai Bio Latest Developments
13.16 Siemens Healthineers
13.16.1 Siemens Healthineers Company Information
13.16.2 Siemens Healthineers Hepatitis A Viruses Rapid Testing Product Portfolios and Specifications
13.16.3 Siemens Healthineers Hepatitis A Viruses Rapid Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Siemens Healthineers Main Business Overview
13.16.5 Siemens Healthineers Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂